Endothelin-1 expression in prostate cancer and high grade prostatic intraepithelial neoplasia

Analytical and Quantitative Cytology and Histology

Volumn 31, Issue 3, 2009, Pages 137-142

  Rosenblatt, Robert ^a   Valdman, Alexander ^a   Cheng, Liang ^b   Lopez Beltran, Antonio ^c   Montironi, Rodolfo ^d   Ekman, Peter ^e   Egevad, Lars ^e,f  

^a KAROLINSKA INSTITUTE   (Sweden)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Universidad de Cordoba   (Spain)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Endothelin type 1; Immunohistochemistry; Prostate neoplasms

Indexed keywords

ENDOTHELIN 1; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; CANCER GROWTH; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HAZARD RATIO; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEMINAL VESICLE; TISSUE MICROARRAY; UNIVARIATE ANALYSIS;

ADULT; AGED; ENDOTHELIN-1; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 67849124048     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Cancer Facts and Figures 2007. Atlanta, American Cancer Society, 2007
2. Nelson J, Bagnato A, Battistini B, Nisen P: The endothelin axis: Emerging role in cancer. Nat Rev Cancer 2003;3:110-116 (Pubitemid 37328878)
3. Nelson JB, Chan-Tack K, Hedican SP, Magnuson SR, Opgenorth TJ, Bova GS, Simons JW: Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer Res 1996;56:663-668 (Pubitemid 26059878)
4. Shipp MA, Tarr GE, Chen CY, Switzer SN, Hersh LB, Stein H, Sunday ME, Reinherz EL: CD10/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung. Proc Natl Acad Sci USA 1991;88:10662-10666 (Pubitemid 21915897)
5. Papandreou CN, Usmani B, Geng Y, Bogenrieder T, Freeman R, Wilk S, Finstad CL, Reuter VE, Powell CT, Scheinberg D, Magill C, Scher HI, Albino AP, Nanus DM: Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nat Med 1998;4:50-57 (Pubitemid 28133079)
6. Jeronimo C, Henrique R, Campos PF, Oliveira J, Caballero OL, Lopes C, Sidransky D: Endothelin B receptor gene hypermethylation in prostate adenocarcinoma. J Clin Pathol 2003;56:52-55 (Pubitemid 36132475)
7. Nelson JB, Hedican SP, George DJ, Reddi AH, Piantadosi S, Eisenberger MA, Simons JW: Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat Med 1995;1:944-949
8. Godara G, Cannon GW, Cannon GM Jr, Bies RR, Nelson JB, Pflug BR: Role of endothelin axis in progression to aggressive phenotype of prostate adenocarcinoma. Prostate 2005; 65:27-34 (Pubitemid 41318828)
9. Godara G, Pecher S, Jukic DM, D'Antonio JM, Akhavan A, Nelson JB, Pflug BR: Distinct patterns of endothelin axis expression in primary prostate cancer. Urology 2007;70:209-215 (Pubitemid 47081092)
10. Montironi R, Mazzucchelli R, Barbisan F, Stramazzotti D, Santinelli A, Lopez Beltran A, Cheng L, Montorsi F, Scarpelli M: Immunohistochemical expression of endothelin-1 and endothelin-A and endothelin-B receptors in high-grade prostatic intraepithelial neoplasia and prostate cancer. Eur Urol 2007;52:1682-1689 (Pubitemid 350052394)
11. Arun C, DeCatris M, Hemingway DM, London NJ, O'Byrne KJ: Endothelin-1 is a novel prognostic factor in non-small cell lung cancer. Int J Biol Markers 2004;19:262-267 (Pubitemid 40124846)
12. Boldrini L, Gisfredi S, Ursino S, Faviana P, Lucchi M, Melfi F, Mussi A, Basolo F, Fontanini G: Expression of endothelin-1 is related to poor prognosis in non-small cell lung carcinoma. Eur J Cancer 2005;41:2828-2835 (Pubitemid 41713120)
13. Arun C, London NJ, Hemingway DM: Prognostic significance of elevated endothelin-1 levels in patients with colorectal cancer. Int J Biol Markers 2004;19:32-37 (Pubitemid 38515009)
14. Rosano L, Varmi M, Salani D, Di Castro V, Spinella F, Natali PG, Bagnato A: Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells. Cancer Res 2001;61:8340-8346 (Pubitemid 33091630)
15. Bagnato A, Cirill, A, Salani D, Simeone P, Muller A, Nicotra MR, Natali PG, Venuti A: Growth inhibition of cervix carcinoma cells in vivo by endothelin A receptor blockade. Cancer Res 2002;62:6381-6384 (Pubitemid 35364090)
16. Giaid A, Hamid QA, Springall DR, Yanagisawa M, Shinmi O, Sawamura T, Masaki T, Kimura S, Corrin B, Polak JM: Detection of endothelin immunoreactivity and mRNA in pulmonary tumours. J Pathol 1990;162:15-22 (Pubitemid 20291444)
17. Ahmed SI, Thompson J, Coulson JM, Woll PJ: Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium. Am J Respir Cell Mol Biol 2000;22:422-431 (Pubitemid 30343341)
18. Asham E, Shankar A, Loizidou M, Fredericks S, Miller K, Boulos PB, Burnstock G, Taylor I: Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ET(A) receptor antagonism. Br J Cancer 2001;85:1759-1763 (Pubitemid 34081524)
19. Venuti A, Salani D, Manni V, Poggiali F, Bagnato A: Expression of endothelin 1 and endothelin A receptor in HPVassociated cervical carcinoma: New potential targets for anticancer therapy. Faseb J 2000;14:2277-2283 (Pubitemid 30843923)
20. Pagotto U, Arzberger T, Hopfner U, Sauer J, Renner U, Newton CJ, Lange M, Uhl E, Weindl A, Stalla GK: Expression and localization of endothelin-1 and endothelin receptors in human meningiomas: Evidence for a role in tumoral growth. J Clin Invest 1995;96:2017-2025
21. Pagotto U, Arzberger T, Hopfner U, Weindl A, Stalla GK: Cellular localization of endothelin receptor mRNAs (ETA and ETB) in brain tumors and normal human brain. J Cardiovasc Pharmacol (suppl 3) 1995;26:S104-S106
22. Battistini B, Chailler P, D'Orleans-Juste P, Briere N, Sirois P: Growth regulatory properties of endothelins. Peptides 1993; 14:385-399
23. Salani D, Di Castro V, Nicotra MR, Rosano L, Tecce R, Venuti A, Natali PG, Bagnato A: Role of endothelin-1 in neovascularization of ovarian carcinoma. Am J Pathol 2000;157: 1537-1547 (Pubitemid 30943211)
24. Nelson JB, Udan MS, Guruli G, Pflug BR: Endothelin-1 inhibits apoptosis in prostate cancer. Neoplasia 2005;7:631-637 (Pubitemid 41099416)
25. Filippatos GS, Gangopadhyay N, Lalude O, Parameswaran N, Said SI, Spielman W, Uhal BD: Regulation of apoptosis by vasoactive peptides. Am J Physiol Lung Cell Mol Physiol 2001;281:L749-L761
26. Zheng R, Iwase A, Shen R, Goodman OB Jr, Sugimoto N, Takuwa Y, Lerner DJ, Nanus DM: Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase. Oncogene 2006;25:5942-5952 (Pubitemid 44477288)
27. Gohji K, Kitazawa S, Tamada H, Katsuoka Y, Nakajima M: Expression of endothelin receptor a associated with prostate cancer progression. J Urol 2001;165:1033-1036 (Pubitemid 32156344)
28. Egevad L: Editorial comment: Immunohistochemical expression of endothelin-1 and endothelin-a and endothelin-b receptors in high-grade prostatic intraepithelial neoplasia and prostate cancer. Eur Urol 2007;52:1689-1690 (Pubitemid 350052395)
29. Prayer-Galetti T, Rossi GP, Belloni AS, Albertin G, Battanello W, Piovan V, Gardiman M, Pagano F: Gene expression and autoradiographic localization of endothelin-1 and its receptors A and B in the different zones of the normal human prostate. J Urol 1997;157:2334-2339 (Pubitemid 27208717)